ESC Professional Premium Access

Comparison of clinical and economic burden of pulmonary arterial hypertension patients with and without connective tissue disease treated with macitentan

Congress Presentation

About the speaker

Doctor Carly Worden

Janssen Pharmaceuticals, Titusville (United States of America)
0 follower

4 more presentations in this session

Persistence with macitentan versus other endothelin receptor antagonists in patients with pulmonary arterial hypertension: experience from a real-world data repository in the USA

Speaker: Doctor S. Panjabi (San Mateo, US)


Additional opportunities for antihypertensive therapy improvement in young patients with arterial hypertension and concomitant obesity

Speaker: Doctor K. Chernyshova (Odessa, UA)


The music therapy effectiveness in hypertensive patients with acute myocardial infarction after previous coronary artery bypass surgery; 18-year experience of the MUSIC study

Speaker: Professor P. Mitrovic (Belgrade, RS)


Angiotensin receptor blockers are equally effective in women and men; a systematic review and meta-analysis

Speaker: Mrs S. Laven (Maastricht, NL)


Access the full session

Hypertension - Treatment lifestyle and pharmacotherapy

Speakers: Doctor C. Worden, Doctor S. Panjabi, Doctor K. Chernyshova, Professor P. Mitrovic, Mrs S. Laven

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb